Clinical Trial Update: "Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL

View source ↗

Summary

A clinical trial update for TRINEG-ALL investigating triple-negative adult B-cell acute lymphoblastic leukemia is currently recruiting. Sponsor IRST S.r.l. IRCC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Leukemia, Lymphoblastic | Status: RECRUITING